These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 1445490)

  • 1. Effect of low-dose probucol therapy on LDL oxidation and the plasma lipoprotein profile in male volunteers.
    Cristol LS; Jialal I; Grundy SM
    Atherosclerosis; 1992 Nov; 97(1):11-20. PubMed ID: 1445490
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of probucol dosage on plasma lipid and lipoprotein levels and on protection of low density lipoprotein against in vitro oxidation in humans.
    Reaven PD; Parthasarathy S; Beltz WF; Witztum JL
    Arterioscler Thromb; 1992 Mar; 12(3):318-24. PubMed ID: 1547191
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low-dose colestipol plus probucol for hypercholesterolemia.
    Dujovne CA; Chernoff SB; Krehbiel P; Jackson B; DeCoursey S; Taylor H
    Am J Cardiol; 1984 Jun; 53(11):1514-8. PubMed ID: 6375337
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antioxidants decreases the intensification of low density lipoprotein in vivo peroxidation during therapy with statins.
    Lankin VZ; Tikhaze AK; Kukharchuk VV; Konovalova GG; Pisarenko OI; Kaminnyi AI; Shumaev KB; Belenkov YN
    Mol Cell Biochem; 2003 Jul; 249(1-2):129-40. PubMed ID: 12956408
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The in vitro and ex vivo antioxidant properties, and hypolipidemic activity of CGP 2881.
    Feldman DL; Mogelesky TC; Sharif R; Sawyer WK; Jeune M; Hu CW; Leonards KS; Prescott MF
    Atherosclerosis; 1999 Jun; 144(2):343-55. PubMed ID: 10407495
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vitamin E supplementation increases the resistance of both LDL and HDL to oxidation and increases cholesteryl ester transfer activity.
    Arrol S; Mackness MI; Durrington PN
    Atherosclerosis; 2000 May; 150(1):129-34. PubMed ID: 10781643
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Probucol with colestipol in the treatment of hypercholesterolemia.
    Dujovne CA; Krehbiel P; Decoursey S; Jackson B; Chernoff SB; Pitterman A; Garty M
    Ann Intern Med; 1984 Apr; 100(4):477-82. PubMed ID: 6367578
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative study on the effect of low-dose vitamin E and probucol on the susceptibility of LDL to oxidation and the progression of atherosclerosis in Watanabe heritable hyperlipidemic rabbits.
    Kleinveld HA; Demacker PN; Stalenhoef AF
    Arterioscler Thromb; 1994 Aug; 14(8):1386-91. PubMed ID: 8049202
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of low density lipoprotein oxidation by thyronines and probucol.
    Hanna AN; Feller DR; Witiak DT; Newman HA
    Biochem Pharmacol; 1993 Feb; 45(3):753-62. PubMed ID: 8442772
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of hypercholesterolemia-induced atherosclerosis in the nonhuman primate by probucol. I. Is the extent of atherosclerosis related to resistance of LDL to oxidation?
    Sasahara M; Raines EW; Chait A; Carew TE; Steinberg D; Wahl PW; Ross R
    J Clin Invest; 1994 Jul; 94(1):155-64. PubMed ID: 8040256
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of effects of probucol versus vitamin E on ex vivo oxidation susceptibility of lipoproteins in hyperlipoproteinemia.
    Dujovne CA; Harris WS; Gerrond LL; Fan J; Muzio F
    Am J Cardiol; 1994 Jul; 74(1):38-42. PubMed ID: 8017303
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of probucol on low density lipoprotein oxidation and femoral atherosclerosis.
    Regnström J; Walldius G; Nilsson S; Elinder LS; Johansson J; Mölgaard J; Holme I; Olsson AG; Nilsson J
    Atherosclerosis; 1996 Sep; 125(2):217-29. PubMed ID: 8842353
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of probucol and vitamin E treatment on the oxidation of low-density lipoprotein and forearm vascular responses in humans.
    McDowell IF; Brennan GM; McEneny J; Young IS; Nicholls DP; McVeigh GE; Bruce I; Trimble ER; Johnston GD
    Eur J Clin Invest; 1994 Nov; 24(11):759-65. PubMed ID: 7890014
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of oxidized lipoproteins in the pathogenesis of atherosclerosis.
    Kita T; Yokode M; Ishii K; Kume N; Nagano Y; Arai H; Otani H; Ueda Y; Hara S
    Clin Exp Pharmacol Physiol Suppl; 1992; 20():37-42. PubMed ID: 1446408
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of policosanol treatment on the susceptibility of low density lipoprotein (LDL) isolated from healthy volunteers to oxidative modification in vitro.
    Menéndez R; Más R; Amor AM; González RM; Fernández JC; Rodeiro I; Zayas M; Jiménez S
    Br J Clin Pharmacol; 2000 Sep; 50(3):255-62. PubMed ID: 10971310
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dietary probucol preserves endothelial function in cholesterol-fed rabbits by limiting vascular oxidative stress and superoxide generation.
    Keaney JF; Xu A; Cunningham D; Jackson T; Frei B; Vita JA
    J Clin Invest; 1995 Jun; 95(6):2520-9. PubMed ID: 7769097
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of concentrated n-3 fatty acids versus gemfibrozil on plasma lipoproteins, low density lipoprotein heterogeneity and oxidizability in patients with hypertriglyceridemia.
    Stalenhoef AF; de Graaf J; Wittekoek ME; Bredie SJ; Demacker PN; Kastelein JJ
    Atherosclerosis; 2000 Nov; 153(1):129-38. PubMed ID: 11058707
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pravastatin vs. probucol in the treatment of hypercholesterolemia. A double-blind study].
    Sienra-Pérez JC; Lerman-Garber I; Ahumada-Ayala M; Castañón-Romo C; Cardoso-Saldaña G; Laguna-Castellanos M; Posadas-Romero C
    Arch Inst Cardiol Mex; 1991; 61(4):365-73. PubMed ID: 1953212
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of probucol on plasma lipids and lipoproteins in type IIb hyperlipoproteinemia.
    Hunninghake DB; Bell C; Olson L
    Atherosclerosis; 1980 Nov; 37(3):469-74. PubMed ID: 7458992
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Probucol protects low-density lipoproteins from in vitro and in vivo oxidation.
    Bittolo-Bon G; Cazzolato G; Avogaro P
    Pharmacol Res; 1994; 29(4):337-44. PubMed ID: 7971685
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.